Enhanced expression of Gal-9 has been associated with improved overall survival in various solid cancers, including colon and hepatocellular cancer, as well as improved disease-free survival in gastric and non-small-cell lung cancer (49). Here, LGALS9 is linked to hepatocellular carcinoma.